Avalo Therapeutics names Taylor Boyd chief business officer Oct 1, 2025 07:00AM
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources Oct 1, 2025 07:00AM
RBC Capital Downgrades Avalo Therapeutics Inc. (AVTX) to Sector Perform Jun 27, 2023 06:24AM
Avalo to Present at the 2023 RBC Capital Markets Global Healthcare Conference May 10, 2023 07:00AM
Avalo Therapuetics (AVTX) Prices 3.77M Share Offering at $3.98/sh Feb 3, 2023 05:54AM


Feb 2, 2023 09:54PM Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants
Feb 2, 2023 09:54PM Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants
Feb 2, 2023 04:03PM Avalo Therapuetics (AVTX) Announces Proposed Stock Offering
Feb 2, 2023 04:01PM Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants
Feb 2, 2023 04:01PM Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants
Sep 24, 2021 06:44AM UPDATE: RBC Capital Starts Avalo Therapeutics Inc. (AVTX) at Outperform
Sep 17, 2021 09:11AM Avalo Therapeutics, Inc. Announces Closing of a $31.5 Million Public Offering of Common Stock, Including Proceeds from Exercise of Option to Purchase Additional Shares
Sep 17, 2021 09:11AM Avalo Therapeutics, Inc. Announces Closing of a $31.5 Million Public Offering of Common Stock, Including Proceeds from Exercise of Option to Purchase Additional Shares
Sep 15, 2021 06:17AM Advance Technologies Inc (AVTX) Prices 12.5M Share Offering at $2.2/sh
Sep 14, 2021 10:23PM Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock
Sep 14, 2021 10:23PM Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock
Sep 14, 2021 04:01PM Advance Technologies Inc (AVTX) Announces Proposed Public Offering of Common Stock
Sep 14, 2021 04:01PM Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Sep 14, 2021 04:01PM Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock